Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Long-Term Deferred Tax (2016 - 2017)

Historic Long-Term Deferred Tax for Wave Life Sciences (WVE) over the last 3 years, with Q2 2017 value amounting to $774000.0.

  • Wave Life Sciences' Long-Term Deferred Tax rose 30312.5% to $774000.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $774000.0, marking a year-over-year increase of 30312.5%. This contributed to the annual value of $560000.0 for FY2016, which is 19166.67% up from last year.
  • As of Q2 2017, Wave Life Sciences' Long-Term Deferred Tax stood at $774000.0, which was up 30312.5% from $774000.0 recorded in Q1 2017.
  • In the past 5 years, Wave Life Sciences' Long-Term Deferred Tax registered a high of $774000.0 during Q1 2017, and its lowest value of $32000.0 during Q3 2016.
  • For the 3-year period, Wave Life Sciences' Long-Term Deferred Tax averaged around $388000.0, with its median value being $192000.0 (2015).
  • In the last 5 years, Wave Life Sciences' Long-Term Deferred Tax surged by 19166.67% in 2016 and then surged by 30312.5% in 2017.
  • Wave Life Sciences' Long-Term Deferred Tax (Quarter) stood at $192000.0 in 2015, then soared by 191.67% to $560000.0 in 2016, then skyrocketed by 38.21% to $774000.0 in 2017.
  • Its Long-Term Deferred Tax was $774000.0 in Q2 2017, compared to $774000.0 in Q1 2017 and $560000.0 in Q4 2016.